# EDGAR Filing Document

**Accession Number:** 0002020932
**File Stem:** 0001354457-26-000141
**Filing Date:** 2026-2
**Character Count:** 1205
**Document Hash:** a945df51ed7b2b89cbe096f534e642a2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001354457-26-000141.hdr.sgml**: 20260205

**ACCESSION NUMBER**: 0001354457-26-000141

**CONFORMED SUBMISSION TYPE**: CERT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260205

**DATE AS OF CHANGE**: 20260205

**EFFECTIVENESS DATE**: 20260205

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Agomab Therapeutics NV
- **CENTRAL INDEX KEY:** 0002020932
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** C9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CERT
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43098
- **FILM NUMBER:** 26601076

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** POSTHOFLEI 1/6
- **CITY:** ANTWERPEN
- **PROVINCE COUNTRY:** C9
- **ZIP:** 2600
- **BUSINESS PHONE:** 32 3 302 35 30

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** POSTHOFLEI 1/6
- **CITY:** ANTWERPEN
- **PROVINCE COUNTRY:** C9
- **ZIP:** 2600

### Attached PDF Documents

**Attachment 1:** `AGMB_8A_Cert_0002020932.pdf`

_No text found in this document._